UNC and NASA Study COVID-19, Protein Correlation

May 8, 2020

UNC biochemist and age researcher Jonathan Schisler is part of the Coronavirus International Research Team, an interdisciplinary research working group formed by NASA to analyze COVID-19 data to address different aspects of the virus.

Understanding COVID-19 Cases with Mild or No Symptoms

May 7, 2020

UNC researchers Ross Boyce and Allison Aiello are leading a study to understand how widespread cases of COVID-19 with mild or no symptoms are in the state and to monitor the prevalence of the disease over time.

Coronavirus May Impact Eating Disorder Recovery

May 6, 2020

Unlike COVID-19, eating disorders thrive in isolation, according to UNC researcher Cynthia Bulik. With an estimated 30 million Americans living with some type of eating disorder, nationwide stay-at-home orders challenge the health and recovery of many. 

RUNC: Rachel Despard

May 6, 2020

Rachel Despard is a senior majoring in music with minors in public policy and social and economic justice within the UNC College of Arts & Sciences. She studies how recorded music boosts community collaboration, affects visibility for vulnerable populations, and … Continued

During a Pandemic, Strong Public Policy Can Save Lives

May 5, 2020

Benjamin Mason Meier is analyzing policies across the globe that are being implemented to halt the spread of COVID-19. He wants to understand what powers governments have to prevent the disease and what policies are working in the disease response.

N.C. Policy Collaboratory to Study Coronavirus

May 4, 2020

The UNC-based N.C. Policy Collaboratory will receive $29 million to study treatment, community testing, and prevention of COVID-19 under a $1.5 billion coronavirus relief package approved by state legislators and signed by Governor Roy Cooper.

The FastTraCS to Solutions

May 1, 2020

FastTraCS is a small group of biomedical engineers who support UNC Health physicians, nurses, and staff by identifying problems in clinical settings and creating innovative, technological solutions. Here’s how team member Devin Hubbard is responding during COVID-19.

Remdesivir Proves Effective Against COVID-19

April 30, 2020

Remdesivir, a drug developed by Gilead Sciences and tested at the UNC Gillings School of Global Public Health, proves effective against COVID-19 in NIAID human clinical trials.